首页 | 本学科首页   官方微博 | 高级检索  
检索        

重症医学科多重耐药菌致HAP的危险因素及治疗情况分析
引用本文:韩静静,徐亚青,何宇红,周晨亮,叶青,余虹,周红霞,成于珈.重症医学科多重耐药菌致HAP的危险因素及治疗情况分析[J].中国感染控制杂志,2015,14(6):374-378.
作者姓名:韩静静  徐亚青  何宇红  周晨亮  叶青  余虹  周红霞  成于珈
作者单位:重症医学科多重耐药菌致HAP的危险因素及治疗情况分析
基金项目:

中华医院感染控制研究基金(ZHYY2014-0017)

摘    要:目的分析重症监护病房(ICU)多重耐药菌(MDRO)致医院获得性肺炎(HAP)的危险因素及其抗菌药物使用情况,进行风险评估并指导抗菌药物使用。方法对2012年1月—2013年12月ICU HAP患者进行回顾性队列研究,分析发生多重耐药(MDR)-HAP的危险因素,以及抗菌药物使用的合理性。结果ICU发生HAP110例,其中MDR-HAP63例(占57.27%)。logistic回归分析结果显示,近期住院时间≥5 d(OR=19.94)、直接从其他医疗机构转入(OR=19.33)、感染类型为晚发HAP(OR=7.98)、近90 d接受抗菌药物治疗(OR=3.42)是发生MDR-HAP的独立危险因素。初始经验性抗感染治疗:MDR-HAP组与非MDR-HAP组在临床诊断24 h内给药时机、抗菌药物品种选择合理率比较,差异无统计学意义(均P0.05);MDR-HAP组病原菌覆盖率为73.02%,低于非MDR-HAP组的91.49%(P0.05)。抗菌药物目标性治疗:两组品种选择,剂量、频次合理率比较,差异无统计学意义(均P0.05);MDR-HAP组抗菌药物使用疗程合理率高于非MDR-HAP组,联合用药合理率略低于后者(均P0.05)。结论 ICU应对患者进行MDR-HAP危险因素评估,并制定相应的预防与控制策略,以降低MDR-HAP的发生率,医务人员应以此为依据规范初始经验性抗感染治疗。

关 键 词:医院获得性肺炎    多重耐药菌     危险因素    抗菌药物    重症医学科    重症监护病房  
收稿时间:2014-09-10
修稿时间:2015/1/12 0:00:00

Risk factors and treatment of hospital acquired pneumonia due to multidrug resistant organisms in intensive care unit
HAN Jing jing,XU Ya qing,HE Yu hong,ZHOU Chen liang,YE Qing,YU Hong,ZHOU.Risk factors and treatment of hospital acquired pneumonia due to multidrug resistant organisms in intensive care unit[J].Chinese Journal of Infection Control,2015,14(6):374-378.
Authors:HAN Jing jing  XU Ya qing  HE Yu hong  ZHOU Chen liang  YE Qing  YU Hong  ZHOU
Institution:Renmin Hospital of Wuhan University, Wuhan 430060,China
Abstract:ObjectiveTo analyze risk factors and antimicrobial use for hospital acquired pneumonia (HAP) due to multidrug resistant organisms (MDROs) in an intensive care unit(ICU), so as to perform risk assessment and guide antimicrobial use.MethodsFrom January 2012 to December 2013, HAP patients were conducted retrospective cohort study, risk factors for MDRO HAP and rationality of antimicrobial use were analyzed. ResultsA total of 110 cases of HAP occurred in ICU, 63 cases (57.27%) were MDR HAP. Logistic regression analysis revealed that recent hospital stay ≥5 days (OR=19.94), transference from other hospitals (OR=19.33), infection type of late onset HAP (OR=7.98), and antimicrobial use in recent 90 days (OR=3.42) were independent risk factors for MDR HAP. Initial empirical anti infective treatment revealed that there were no significant difference in timing of antimicrobial administration within 24 hours after clinical diagnosis was confirmed, and rationality of antimicrobial selection between MDR HAP group and non MDR HAP group (both P>0.05); The isolation rate of pathogens in MDR HAP group was lower than non MDR HAP group (73.02% vs 91.49% P<0.05).Targeted antimicrobial therapy revealed that there were no significant difference in selection, dosage, and frequency of antimicrobial use between two groups(all P>0.05); the rationality rate of therapy course in MDR HAP group was higher than no MDR HAP group, but rationality rate of combination use of antimicrobial agents was slightly lower than the latter(both P<0.05).ConclusionPatients in ICU should be conducted risk factor assessment, and according prevention and control measures should be formulated, so as to reduce the occurrence of MDR HAP,health care workers should standardized the initial empirical anti infective treatment.
Keywords:hospital acquired pneumonia  multidrug resistant organism     risk factor  antimicrobial agent  intensive care medicine  intensive care unit  
本文献已被 CNKI 等数据库收录!
点击此处可从《中国感染控制杂志》浏览原始摘要信息
点击此处可从《中国感染控制杂志》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号